Vaishali Pharma

What Vaishali Pharma does

Vaishali Pharma Limited is a publicly listed Indian pharmaceutical company founded in 1989 (originally as Vaishali Pharmachem) and headquartered in Mumbai. It manufactures and exports a diversified portfolio spanning Active Pharmaceutical Ingredients (APIs), finished formulations (250+ brands across antibiotics, antidiabetic, antimalarial, cardiovascular, and dermatological categories), surgical disposables, veterinary medicines, herbal/Ayurvedic formulations, nutraceuticals, and oncology products. Manufacturing is executed through partner facilities accredited to WHO-GMP, EU-GMP, and USFDA standards, with Vaishali functioning as the export-trading, dossier-owning, and marketing entity under a relatively asset-light model.

The company targets B2B pharmaceutical distributors, wholesalers, and institutional buyers across 30+ countries spanning Asia-Pacific, Africa, CIS, the Middle East, and the Americas, with additional domestic Indian branded-pharma activity since 2024. Go-to-market combines direct export sales, participation in international trade shows (Arab Health, IPHEX, CPHI, Vita Foods), and country-level joint ventures in Kenya, Russia, and D.R. Congo. CTD-format dossiers with bioequivalence data support multi-jurisdiction registrations, and country-specific accreditations (Peru-DIGIMED, NAFDAC, FMHACA) enable targeted emerging-market access.

Vaishali Pharma is listed on the NSE main board (ticker VAISHALI) since 2020, after migrating from the SME Emerge platform. FY2025-26 revenue reached Rs 108.77 crore with net profit of Rs 4.03 crore. Founder Atul Vasani remains Chairman and Managing Director. Recent inorganic moves include the 2022 Sankalp LifeCare marketing takeover, the 2022 Jark Pharma agreement, and the 2025 Kesar Pharma acquisition, while recent product launches (Edetoxin, Viprofol, nutraceutical sprays, dermatological antifungals) signal a push into higher-complexity therapeutics and branded consumer health.

Name

Vaishali Pharma

Legal name

Vaishali Pharma Limited

Website

https://www.vaishalipharma.com/

Company type

Public

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

Vaishali Pharma is a publicly listed Mumbai-based pharmaceutical company that exports APIs, formulations (250+ brands), surgical, veterinary, nutraceutical, and oncology products to distributors across 30+ countries through partner manufacturing facilities.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Oncology Specialty Pharmaceuticals (HLAIACAA)

Keywords

• Pharmaceutical formulations
• Active pharmaceutical ingredients
• Pharmaceutical exports
• Nutraceutical supplements
• Surgical medical disposables

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Formulation Manufacturing and Export: Manufactures and exports finished pharmaceutical formulations across therapeutic categories including antibiotics, antidiabetic, antimalarial, cardiovascular, and dermatological products. More than 250 formulation brands are marketed in multiple countries.
2. Active Pharmaceutical Ingredients (API): Offers one of the broadest portfolios of APIs including antibiotics, anti-ulcer, anti-inflammatory, corticosteroids, anti-malarial, cardiac, anti-diabetic, and anti-fungal ingredients. Acts as API supplier for reputed companies.
3. Surgical Products: Provides surgical products including disposable syringes, IV cannulas, gloves, catheters, masks, and other hospital medical requirements.
4. Veterinary Pharmaceuticals: Markets veterinary pharmaceutical products globally with focus on anthelmintics, antibiotics, vitamins, and feed supplements for livestock.
5. Nutraceutical Products: Delivers wide range of nutraceutical products including vitamins, minerals, dietary supplements, and health products for immunity building, probiotics, and chronic disease prevention.
6. Oncology Products: Dedicated division for anticancer products including liquid formulations, tablets, capsules, and lyophilized forms of chemotherapy agents.
7. Herbal Products: Markets herbal and Ayurvedic products including supplements for various health conditions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Vaishali Pharma manufactures and exports pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs), surgical disposables, nutraceuticals, veterinary medicines, oncology products, and herbal/Ayurvedic products to 30+ countries globally. The company markets 250+ formulation brands through CTD-format dossiers with bioequivalence data, leveraging WHO-GMP, EU-GMP, and USFDA aligned manufacturing partnerships for international regulatory compliance.

Product overview

Vaishali Pharma Limited is a pharmaceutical company offering a diversified portfolio of healthcare products organized across multiple product categories: Active Pharmaceutical Ingredients (APIs) - the therapeutic components for different medicines; Finished Formulations - various dosage forms in therapeutic categories including antibiotics, antidiabetics, antimalarials; more than 250+ formulation brands marketed internationally; Surgical products - disposable medical supplies; Herbal products - traditional medicine formulations; Veterinary products - animal health pharmaceuticals; Nutraceutical products - dietary supplements, vitamins, and health products; and Oncology products - dedicated anticancer medications. The company recently launched new products including sedatives (Edetoxin, Viprofol), nutraceutical sprays (Vipravita Sprays), and vitamin supplements. Through partnerships with Sankalp LifeCare, they have expanded their nutraceutical offerings. Products are manufactured under WHO-GMP and international accreditations with dossier in CTD format for global markets.

Differentiator

Problem solved

Functional benefit

Brands

• Vipravita: Multivitamin and nutraceutical product line including Vipravita C, Vipravita CZ, Vipravita D3, Vipravita Spray, and related supplements
• Azibiotek
• Mythrocin
• Quixinclav
• Viprox
• Fitofin
• Mositon
• Edetoxin
• Viprofol
• Fungiquick
• Conazal

Products and services

• Active Pharmaceutical Ingredients (APIs) Broad portfolio of Active Pharmaceutical Ingredients including antibiotics, anti-ulcer, anti-inflammatory, corticosteroids, anti-malarial, cardiac, anti-diabetic, anti-viral, and anti-fungal APIs supplied to pharmaceutical manufacturers and reputed companies.
• Finished Formulations Wide range of finished pharmaceutical formulations including antibiotics, anti-ulcer, anti-malarial, anti-cold, anti-fungal, vitamins, topical steroids, anti-inflammatory, cardiovascular, and anti-diabetic products in various dosage forms, recognized for high quality and effectiveness in international markets.
• Formulation Brands (250+ brands) More than 250 formulation brands marketed in multiple countries with CTD-format dossiers including antibiotics, anti-inflammatory, anti-fungal, cardiovascular, anti-diabetic, and multivitamin products under brand names such as Azibiotek, Viprox, Fitofin, and others.
• Surgical Products Disposable surgical products including infusion sets, IV cannulas, syringes, needles, gloves, catheters, masks, and surgical blades for hospital and medical requirements, manufactured under ISO 13485:2016 certification and CE marking.
• Herbal Products Herbal medicine products including Tadalsa, Rosaqua, Tvingoff, Mumio, Hairnique, Kwatha, Amygdalus, Gulqand, and other herbal/Ayurvedic formulations marketed for various therapeutic uses.
• Veterinary Pharmaceuticals Veterinary pharmaceutical products including multivitamins, minerals, anthelmintics, anti-bacterials, probiotics, feed supplements, and injectable solutions for livestock health, marketed globally at affordable prices.
• Nutraceutical Products Wide range of nutraceutical products including anti-stress, antioxidant, brain health, calcium, cardio health, diabetic control, digestive enzymes, eye care, fertility supplements, gynaecological, hair/nail/skin, immunity boosters, joint care, and weight loss products, including the Vipravita brand range.
• Oncology Products Dedicated anticancer products including liquid form injectables (Carboplatin, Cisplatin, Paclitaxel, Doxorubicin), tablets (Abiraterone, Anastrozole, Imatinib), lyophilized forms, and capsules for cancer treatment.
• Edetoxin (Dexmedetomidine 100 mcg) Sedative injection (Dexmedetomidine 100 mcg) used for adult patients in intensive care settings before and during surgical procedures.
• Viprofol (Propofol 1%) General anesthetic injection (Propofol 1%) used in major surgical procedures to induce loss of consciousness, available in 20 ml strength.
• Vipravita Sprays (Nutraceutical Sprays) Unique spray-based nutritional supplements including Folic Acid + Vitamin B12 spray, Vitamin D3 spray, Multi-Vitamin spray, and Folic Acid spray, offering a sugar-free, portable, faster-absorbing alternative to capsules and tablets.
• Fungiquick (Itraconazole 100 mg) Antifungal capsules (Itraconazole 100 mg) for treatment of fungal infections.
• Conazal (Luliconazole 1% w/w) Topical antifungal cream (Luliconazole 1% w/w) for skin fungal infections, available in 30gm packaging.
• Go Corona Kit COVID-19 related product kit launched during the pandemic period for protection and treatment support.

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered minor and core.

• Kesar Pharma LtdminorOthers · 1 January 2026Vaishali Pharma Ltd will receive Rs 2,15,258 from Kesar Pharma Ltd as adjustment to preferential allotment consideration based on a registered valuer's report. The adjustment addresses a Rs 0.10 per share difference on 21,52,575 shares being acquired. This is a routine valuation-driven correction to the agreed share purchase price.
• Sankalp LifeCarecoreStrategic or Co-development Partner · 1 January 2022Vaishali Pharma signed a partnership agreement with Sankalp LifeCare, an Ahmedabad-based nutraceuticals manufacturer. Under the agreement, Vaishali Pharma took over domestic and international marketing operations of Sankalp LifeCare. This synergistic partnership aims to leverage both companies' strengths in the rapidly growing nutraceuticals segment, with focus on immunity building, probiotics, dietary supplements, and chronic disease prevention products.
• Arochem Industries (Joint Venture)minorStrategic or Co-development PartnerVaishali Pharmachem entered into a joint venture with Arochem Industries, an API manufacturing company, in 1994.
• Kenya-based Company (Joint Venture)minorStrategic or Co-development PartnerJoint venture partnership established to widen reach overseas in African markets.
• Russia-based Company (Joint Venture)minorStrategic or Co-development PartnerJoint venture partnership established to expand presence in CIS/Russian markets.
• D.R. Congo-based Company (Joint Venture)minorStrategic or Co-development PartnerJoint venture partnership established to expand presence in African markets.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/100001429079256

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vaishali Pharma